Cargando…
The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis
The pharmacological management of influenza virus (IV) infections still poses a series of challenges due to the limited anti-IV drug arsenal. Therefore, the development of new anti-influenza agents effective against antigenically different IVs is therefore an urgent priority. To meet this need, host...
Autores principales: | Sibille, Giulia, Luganini, Anna, Sainas, Stefano, Boschi, Donatella, Lolli, Marco Lucio, Gribaudo, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611833/ https://www.ncbi.nlm.nih.gov/pubmed/36298835 http://dx.doi.org/10.3390/v14102281 |
Ejemplares similares
-
The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
por: Calistri, Arianna, et al.
Publicado: (2021) -
The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
por: Gaidano, Valentina, et al.
Publicado: (2021) -
Identification
of Potent hDHODH Inhibitors for Lung
Cancer via Virtual Screening of a Rationally Designed Small Combinatorial
Library
por: Nada, Hossam, et al.
Publicado: (2023) -
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors
por: Shih, Kuei-Chung, et al.
Publicado: (2014) -
Retroviruses of the Human Virobiota: The Recycling of Viral Genes and the Resulting Advantages for Human Hosts During Evolution
por: Luganini, Anna, et al.
Publicado: (2020)